Tear Fluid Biomarkers Show Negligible Differences Across Amyloid Status in Memory Clinics
Neurodegeneration biomarkers are quantifiable in basal tear fluid but exhibit negligible differences across amyloid-positive and amyloid-negative patients in memory clinics.









